Search earnings tickers

GILD

2024Q1AMC

Gilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-04-25 · Fiscal end 2024-03-31 · Features as of 2024-04-25

← Earnings history

Street

Consensus EPS-1.52

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.5%

IV front—

P/C full—

P/C front—

Features as of2024-04-25

Run-up

Close—

Ret 5d-1.3%

Ret 10d-4.9%

Ret 20d-10.6%

Ret 30d-14.1%

Print

Actual EPS

-1.32Beat

Estimated EPS-1.52

Actual revenue

6.7B

Surprise %+13.2%

Beat / missBeat

Beat streak 41

Beat streak 81

Reaction

1-day stock reaction-0.1%

Implied vs actual

Implied 1.5%Actual 0.4%

Gap reaction+0.4%

Day result+0.2%

Next-day upNo

Realized / IV0.23×

Post tape

Post 5d-1.0%

Post 10d+0.8%

Post volume12.4M

Vol ×10d1.64×

Vol ×20d1.81×

Post range2.6%